Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
Just nowMonthly Cash Flow Report - April 2026
Just nowExpiry of Listed Options
Just nowExecutive Chairman's AGM Address to Shareholders
4m agoRevised FY26 Guidance - Timing Delays on Existing Projects
47m agoRehabilitation Completed at Orleans Mine
Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

About

Praxis Precision Medicines, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

May 7 2026
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
May 4 2026
Praxis Precision Medicines to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026, and Participate in Upcoming Investor Conference
Apr 14 2026
Praxis Precision Medicines Announces FDA Acceptance of New Drug Application for Ulixacaltamide HCl in Patients with Essential Tremor
Apr 13 2026
Praxis to Showcase Essential3, the First Positive Phase 3 Program in Essential Tremor, at AAN 2026
Apr 6 2026
Praxis Precision Medicines Announces Positive Results from the EMBRAVE Part A Trial of Elsunersen in Patients with SCN2A Early-Onset Developmental and Epileptic Encephalopathy

Community Chat

Ask AI

6ix6ixAIEvents